Propanedinitrile,2-[(3,4-dihydroxyphenyl)methylene]-;Tyrphostin 23;Tyrphostin A23;AG-18;AG-18 (AG18, Tyrphostin A23, RG-50810);(3,4-Dihydroxybenzylidene)malononitrile RG-50810;2-[(3,4-dihydroxyphenyl)methylidene]propanedinitrile;RG 50810;RG-50810;AG18;(3,4-Dihydroxybenzylidene)malononitrile;2-(3,4-Dihydroxybenzylidene)malononitrile;AG 18 (pharmaceutical);RG 50858;TX 825;Tyrphostin AG 18;Tyrphostin AG 1;AG-18(RG-50810);Tyrphostin A 23;AG18, >=98%;AG 18;Tyrphostin AG18;Tyrphostin RG50810;alpha-Cyano-(3,4-dihydroxy)cinnamonitrile;(3,4-Dihydroxyphenyl)methylene propanedinitrile;RV0GCD31OJ;C10H6N2O2;(3,4-dihydroxybenzylidene)propanedinitrile;DS
Cas No.
118409-57-7
分子式
C10H6N2O2
分子量
186.17
包装储存
Powder
-20°C
3 years
4°C
2 years
In solvent
-80°C
6 months
-20°C
1 month
生物活性
Tyrphostin 23 (Tyrphostin A23) is an EGFR inhibitor with an IC50 and Kiof 35 and 11 μM, respectively.
性状
Solid
IC50 & Target[1][2]
EGFR
35 μM (IC50, Cell Assay)
EGFR
11 μM (Ki)
体外研究(In Vitro)
10 μM tyrphostin 23 causes significant inhibition of the cell proliferation caused by 1 nM and 1μM ghrelin. Tyrphostin 23 (T23) is a well-known inhibitor of protein tyrosine kinases and has been considered as potential anti-cancer drug. T23 is reported to acutely stimulate the glycolytic flux in primary cultured astrocytes. Tyrphostin 23 stimulates glycolytic flux in cultured astrocytes. Mitochondrial metabolism of brain astrocytes is accelerated by Tyrphostin 23 exposure.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.